First Header Logo Second Header Logo

Michael V. Rocco MD, MSCE

TitleProfessor
InstitutionWake Forest School of Medicine
DepartmentInternal Medicine, Nephrology
Address
vCardDownload vCard

    Collapse Biography 
    Collapse awards and honors
    2013Garabed Eknoyan Award , National Kidney Foundation
    2005 - 2021Best Doctors in America
    2011 - 2020Top Doctors in Nephrology, US News and World Report
    2012 - 2021Top Doctor in Nephrology, Castle Connolly

    Collapse Research 
    Collapse research activities and funding
         (BUCKALEW, VARDAMAN M)Nov 1, 1991 - Oct 31, 1993
    NIH
    Modification of Diet in Renal Disease (MDRD)
    Role: Co-Investigator
         (SHUMAER, SALLY)May 20, 1992 - Aug 31, 1997
    NIH
    Renal Disease Epidemiology: Predictors of Outcome (KOPE Study)
    Role: Co-Investigator
    U01DK049271     (ROCCO, MICHAEL V)Sep 30, 1994 - Aug 30, 2003
    NIH
    MMHD Clinical Center. Morbidity and Mortality in Hemodialysis (HD)
         (ROCCO, MICHAEL V)Aug 1, 2003 - Feb 28, 2007
    NIH/VA
    Intensive versus Conventional Renal Support in Acute Renal Failure
    Role: Principal Investigator
         (ROCCO, MICHAEL V)Sep 1, 2003 - Dec 31, 2013
    NIH/NIDDK
    Frequent Hemodialysis Clinical Trial (Nocturnal HD)
    Role: Principal Investigator
    U01DK066480     (ROCCO, MICHAEL V)Sep 30, 2003 - Jan 31, 2013
    NIH
    Frequent Hemodialysis Network (FHN) - Nocturnal Clinical Core Consortium
    Role: Principal Investigator
         (ROCCO, MICHAEL V)Jul 1, 2004 - Sep 28, 2008
    NIH
    Dialysis Access Consortium - Clinical Center
    Role: Principal Investigator
         (ROCCO, MICHAEL V)May 1, 2006 - Dec 31, 2012
    NIH/NIDDK
    Frequent Hemodialysis Clinical Trial (Daily HD)
    Role: Principal Investigator
         (ROCCO, MICHAEL V)Sep 1, 2009 - Mar 31, 2020
    NIH/BHLBI
    Systolic Blood Pressure Intervention Trial (SPRINT) Clinical Coordinating Network
    Role: Principal Investigator
         (HUNDLEY, GREG)Aug 1, 2010 - Aug 31, 2013
    NIH/STTR
    Comprehensive MR Imaging of Elderly Vascular Function, Phase II
    Role: Co-Investigator
         (CHAN, CHRIS)Sep 1, 2011 - Aug 31, 2014
    NIH/NIDDK
    Pathways Influencing Left Ventricular Hypertrophy in Hemodialysis Patients
    Role: Co-Investigator
         (KITZMAN, DALANE)Jul 1, 2012 - Mar 31, 2015
    NIH/NHLBI
    SPRINT - HEART Ancillary Study
    Role: Co-Investigator
         (ROCCO, MICHAEL V)May 1, 2016 - May 31, 2020
    Bayer Health Care
    Study 16244
    Role Description: A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven phase III study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease.
    Role: Principal Investigator - Clinical Site
         (ROCCO, MICHAEL V)May 1, 2016 - Oct 31, 2020
    Bayer Health Care
    Study 17530
    Role Description: A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone on the reduction of cardiovascular morbidity and mortality in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease in addition to standard of care.
    Role: Principal Investigator - Clinical Site
         (ROCCO, MICHAEL V)Sep 1, 2017 - May 31, 2018
    NIH/NHLBI
    Systolic Blood Pressure Intervention Trial: Alzheimer's, Seniors and Kidneys (SPRINT-ASK)
    Role: Principal Investigator
         (ROCCO, MICHAEL V)Aug 17, 2018 - Jun 30, 2022
    NIH/NHLBI
    Blood Pressure and Kidney Function - SPRINT vs Electronic Health Record
    Role: Principal Investigator
         (ROCCO, MICHAEL V)Nov 1, 2018 - Dec 1, 2020
    Danone
    Fluid App for Monitoring Fluid Intake in Chronic Hemodialysis Patients
    Role: Principal Investigator
         (ROCCO, MICHAEL V)Sep 1, 2019 - Aug 31, 2023
    Duke Clinical Research Center/Boehringer Ingelheim
    A multicentre international randomized parallel group double-blind placebo-controlled clinical trial of EMPAgliflozin once daily to assess cardio-renal outcomes in patients with chronic KIDNEY disease
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Glasser SP, Vitolins M, Rocco MV, Still CH, Cofield SS, Haley WE, Goff D. Is Medication Adherence Predictive of Cardiovascular Outcomes and Blood Pressure Control? The Systolic Blood Pressure Intervention Trial (SPRINT). Am J Hypertens. 2022 02 01; 35(2):182-191. PMID: 34528669.
      Citations:    
    2. Bae E, Rocco MV, Lee J, Park JY, Kim YC, Yoo KD, Kim EY, Park DJ, Lim CS, Kim YS, Lee JP. Impact of DBP on all-cause and cardiovascular mortality: results from the National Health and Nutrition Examination survey, 1999-2014. J Hypertens. 2022 01 01; 40(1):108-116. PMID: 34857704.
      Citations:    
    3. Upadhya B, Willard JJ, Lovato LC, Rocco MV, Lewis CE, Oparil S, Cushman WC, Bates JT, Bello NA, Aurigemma G, Johnson KC, Rodriguez CJ, Raj DS, Rastogi A, Tamariz L, Wiggers A, Kitzman DW. Incidence and Outcomes of Acute Heart Failure With Preserved Versus Reduced Ejection Fraction in SPRINT. Circ Heart Fail. 2021 12; 14(12):e008322. PMID: 34823375.
      Citations:    
    4. Wright JT, Whelton PK, Johnson KC, Snyder JK, Reboussin DM, Cushman WC, Williamson JD, Pajewski NM, Cheung AK, Lewis CE, Oparil S, Rocco MV, Beddhu S, Fine LJ, Cutler JA, Ambrosius WT, Rahman M, Still CH, Chen Z, Tatsuoka C. SPRINT Revisited: Updated Results and Implications. Hypertension. 2021 Dec; 78(6):1701-1710. PMID: 34757768.
      Citations:    
    5. Raimann JG, Chan CT, Daugirdas JT, Depner T, Greene T, Kaysen GA, Kliger AS, Kotanko P, Larive B, Beck G, Lindsay RM, Rocco MV, Chertow GM, Levin NW. The Predialysis Serum Sodium Level Modifies the Effect of Hemodialysis Frequency on Left-Ventricular Mass: The Frequent Hemodialysis Network Trials. Kidney Blood Press Res. 2021; 46(6):768-776. PMID: 34644706.
      Citations:    
    6. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2021 05 20; 384(20):1921-1930. PMID: 34010531.
      Citations:    
    7. Campos CL, Jones D, Snively BM, Rocco M, Pedley C, Atwater S, Moore JB. Text Messaging and Home Blood Pressure Monitoring for Patients with Uncontrolled Hypertension: Proposal for a Feasibility Pilot Randomized Controlled Trial. JMIR Res Protoc. 2021 May 14; 10(5):e18984. PMID: 33988513.
      Citations:    
    8. Upadhya B, Pajewski NM, Rocco MV, Hundley WG, Aurigemma G, Hamilton CA, Bates JT, He J, Chen J, Chonchol M, Glasser SP, Hung AM, Pisoni R, Punzi H, Supiano MA, Toto R, Taylor A, Kitzman DW. Effect of Intensive Blood Pressure Control on Aortic Stiffness in the SPRINT-HEART. Hypertension. 2021 May 05; 77(5):1571-1580. PMID: 33775127.
      Citations:    
    9. Ng JK, Smyth B, Marshall MR, Kang A, Pinter J, Bassi A, Krishnasamy R, Rossignol P, Rocco MV, Li Z, Jha V, Hawley CM, Kerr PG, DI Tanna GL, Woodward M, Jardine AM. Relationship between measured and prescribed dialysate sodium in haemodialysis: a systematic review and meta-analysis. Nephrol Dial Transplant. 2021 Mar 29; 36(4):695-703. PMID: 33367715.
      Citations:    
    10. Macedo E, Hemmila U, Sharma SK, Claure-Del Granado R, Mzinganjira H, Burdmann EA, Cerdá J, Feehally J, Finkelstein F, García-García G, Jha V, Lameire NH, Lee E, Levin NW, Lewington A, Lombardi R, Rocco MV, Aronoff-Spencer E, Tonelli M, Yeates K, Remuzzi G, Mehta RL. Recognition and management of community-acquired acute kidney injury in low-resource settings in the ISN 0by25 trial: A multi-country feasibility study. PLoS Med. 2021 01; 18(1):e1003408. PMID: 33444372.
      Citations:    
    11. Malhotra R, Katz R, Jotwani V, Agarwal A, Cohen DL, Cushman WC, Ishani A, Killeen AA, Kitzman DW, Oparil S, Papademetriou V, Parikh CR, Raphael KL, Rocco MV, Tamariz LJ, Whelton PK, Wright JT, Shlipak MG, Ix JH. Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial). Am J Kidney Dis. 2020 Dec 14. PMID: 33333147.
      Citations:    
    12. Rocco MV, Comeau ME, Marion MC, Freedman BI, Hawfield AT, Langefeld CD. Effects of Intensive Systolic Blood Pressure Control on All-Cause Hospitalizations. Hypertension. 2020 12; 76(6):1717-1724. PMID: 33100049.
      Citations:    
    13. O'Lone E, Howell M, Viecelli AK, Craig JC, Tong A, Sautenet B, Herrington WG, Herzog CA, Jafar TH, Jardine M, Krane V, Levin A, Malyszko J, Rocco MV, Strippoli G, Tonelli M, Wang AY, Wanner C, Zannad F, Winkelmayer WC, Wheeler DC. Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals. Nephrol Dial Transplant. 2020 10 01; 35(10):1761-1769. PMID: 32040154.
      Citations:    
    14. Siew ED, Liu KD, Bonn J, Chinchilli V, Dember LM, Girard TD, Greene T, Hernandez AF, Ikizler TA, James MT, Kampschroer K, Kopp JB, Levy M, Palevsky PM, Pannu N, Parikh CR, Rocco MV, Silver SA, Thiessen-Philbrook H, Wald R, Xie Y, Kimmel PL, Star RA. Improving Care for Patients after Hospitalization with AKI. J Am Soc Nephrol. 2020 10; 31(10):2237-2241. PMID: 32912935.
      Citations:    
    15. Contreras G, Lu L, Tamariz L, Rocco MV, Papademetriou V, Kostis JB, Pisoni R, Glasser SP, Sweeney ME, Basile J, Gren LH, Zamanian S, Cushman WC. Outcomes in adults with systolic blood pressure between 130 and 139?mmHg in Action to Control Cardiovascular Risk in Diabetes Blood Pressure trial and Systolic Blood Pressure Intervention Trial. J Hypertens. 2020 08; 38(8):1567-1577. PMID: 32371767.
      Citations:    
    16. Potok OA, Ix JH, Shlipak MG, Katz R, Hawfield AT, Rocco MV, Ambrosius WT, Cho ME, Pajewski NM, Rastogi A, Rifkin DE. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis. 2020 12; 76(6):765-774. PMID: 32682697.
      Citations:    
    17. Chang AR, Kramer H, Wei G, Boucher R, Grams ME, Berlowitz D, Bhatt U, Cohen DL, Drawz P, Punzi H, Freedman BI, Haley W, Hawfield A, Horwitz E, McLouth C, Morisky D, Papademetriou V, Rocco MV, Wall B, Weiner DE, Zias A, Beddhu S. Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria: Post Hoc Analyses from SPRINT. Clin J Am Soc Nephrol. 2020 08 07; 15(8):1121-1128. PMID: 32669306.
      Citations:    
    18. Murea M, Geary RL, Houston DK, Edwards MS, Robinson TW, Davis RP, Hurie JB, Williams TK, Velazquez-Ramirez G, Bagwell B, Tuttle AB, Moossavi S, Rocco MV, Freedman BI, Williamson JD, Chen H, Divers J. A randomized pilot study to evaluate graft versus fistula vascular access strategy in older patients with advanced kidney disease: results of a feasibility study. Pilot Feasibility Stud. 2020; 6:86. PMID: 32551134.
      Citations:    
    19. O'Lone E, Viecelli AK, Craig JC, Tong A, Sautenet B, Herrington WG, Herzog CA, Jafar TH, Jardine M, Krane V, Levin A, Malyszko J, Rocco MV, Strippoli G, Tonelli M, Wang AYM, Wanner C, Zannad F, Winkelmayer WC, Wheeler DC. Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop. Am J Kidney Dis. 2020 07; 76(1):109-120. PMID: 32414662.
      Citations:    
    20. Malhotra R, Katz R, Jotwani V, Ambrosius WT, Raphael KL, Haley W, Rastogi A, Cheung AK, Freedman BI, Punzi H, Rocco MV, Ix JH, Shlipak MG. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD. Clin J Am Soc Nephrol. 2020 03 06; 15(3):349-358. PMID: 32111704.
      Citations:    
    21. Chan CT, Collins K, Ditschman EP, Koester-Wiedemann L, Saffer TL, Wallace E, Rocco MV. Overcoming Barriers for Uptake and Continued Use of Home Dialysis: An NKF-KDOQI Conference Report. Am J Kidney Dis. 2020 06; 75(6):926-934. PMID: 32057468.
      Citations:    
    22. Mandelbrot DA, Reese PP, Garg N, Thomas CP, Rodrigue JR, Schinstock C, Doshi M, Cooper M, Friedewald J, Naik AS, Kaul DR, Ison MG, Rocco MV, Verbesey J, Hladunewich MA, Ibrahim HN, Poggio ED. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Am J Kidney Dis. 2020 03; 75(3):299-316. PMID: 32007233.
      Citations:    
    23. Drawz PE, Beddhu S, Kramer HJ, Rakotz M, Rocco MV, Whelton PK. Blood Pressure Measurement: A KDOQI Perspective. Am J Kidney Dis. 2020 03; 75(3):426-434. PMID: 31864820.
      Citations:    
    24. Pajewski NM, Berlowitz DR, Bress AP, Callahan KE, Cheung AK, Fine LJ, Gaussoin SA, Johnson KC, King J, Kitzman DW, Kostis JB, Lerner AJ, Lewis CE, Oparil S, Rahman M, Reboussin DM, Rocco MV, Snyder JK, Still C, Supiano MA, Wadley VG, Whelton PK, Wright JT, Williamson JD. Intensive vs Standard Blood Pressure Control in Adults 80?Years or Older: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial. J Am Geriatr Soc. 2020 03; 68(3):496-504. PMID: 31840813.
      Citations:    
    25. Chan CT, Kaysen GA, Beck GJ, Li M, Lo JC, Rocco MV, Kliger AS. The effect of frequent hemodialysis on matrix metalloproteinases, their tissue inhibitors, and FGF23: Implications for blood pressure and left ventricular mass modification in the Frequent Hemodialysis Network trials. Hemodial Int. 2020 04; 24(2):162-174. PMID: 31826326.
      Citations:    
    26. Nasrallah IM, Pajewski NM, Auchus AP, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, Davatzikos C, Desiderio L, Doshi J, Erus G, Fine LJ, Gaussoin SA, Harris D, Johnson KC, Kimmel PL, Kurella Tamura M, Launer LJ, Lerner AJ, Lewis CE, Martindale-Adams J, Moy CS, Nichols LO, Oparil S, Ogrocki PK, Rahman M, Rapp SR, Reboussin DM, Rocco MV, Sachs BC, Sink KM, Still CH, Supiano MA, Snyder JK, Wadley VG, Walker J, Weiner DE, Whelton PK, Wilson VM, Woolard N, Wright JT, Wright CB, Williamson JD, Bryan RN. Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions. JAMA. 2019 08 13; 322(6):524-534. PMID: 31408137.
      Citations:    
    27. Beddhu S, Shen J, Cheung AK, Kimmel PL, Chertow GM, Wei G, Boucher RE, Chonchol M, Arman F, Campbell RC, Contreras G, Dwyer JP, Freedman BI, Ix JH, Kirchner K, Papademetriou V, Pisoni R, Rocco MV, Whelton PK, Greene T. Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT. J Am Soc Nephrol. 2019 08; 30(8):1523-1533. PMID: 31324734.
      Citations:    
    28. Upadhya B, Rocco MV, Pajewski NM, Morgan T, Blackshear J, Hundley WG, Oparil S, Soliman EZ, Cohen DL, Hamilton CA, Cho ME, Kostis WJ, Papademetriou V, Rodriguez CJ, Raj DS, Townsend R, Vasu S, Zamanian S, Kitzman DW. Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEART. Hypertension. 2019 Jul 01; HYPERTENSIONAHA11913073. PMID: 31256724.
      Citations:    
    29. Macedo E, Garcia-Garcia G, Mehta RL, Rocco MV. International Society of Nephrology 0 by 25 Project: Lessons Learned. Ann Nutr Metab. 2019; 74 Suppl 3:45-50. PMID: 31203299.
      Citations:    
    30. Macedo E, Rocco MV, Mehta R, Garcia-Garcia G. Safe Water Community Project in Jalisco, Mexico. Ann Nutr Metab. 2019; 74 Suppl 3:51-56. PMID: 31203300.
      Citations:    
    31. Bullen AL, Katz R, Lee AK, Anderson CAM, Cheung AK, Garimella PS, Jotwani V, Haley WE, Ishani A, Lash JP, Neyra JA, Punzi H, Rastogi A, Riessen E, Malhotra R, Parikh CR, Rocco MV, Wall BM, Bhatt UY, Shlipak MG, Ix JH, Estrella MM. The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury. Kidney Int. 2019 08; 96(2):470-479. PMID: 31262489.
      Citations:    
    32. Murea M, Geary RL, Edwards MS, Moossavi S, Davis RP, Goldman MP, Hurie J, Williams TK, Velazquez-Ramirez G, Robinson TW, Bagwell B, Tuttle AB, Callahan KE, Rocco MV, Houston DK, Pajewski NM, Divers J, Freedman BI, Williamson JD. A randomized pilot study comparing graft-first to fistula-first strategies in older patients with incident end-stage kidney disease: Clinical rationale and study design. Contemp Clin Trials Commun. 2019 Jun; 14:100357. PMID: 31016270.
      Citations:    
    33. Kramer HJ, Townsend RR, Griffin K, Flynn JT, Weiner DE, Rocco MV, Choi MJ, Weir MR, Chang TI, Agarwal R, Beddhu S. KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline. Am J Kidney Dis. 2019 04; 73(4):437-458. PMID: 30905361.
      Citations:    
    34. Huang SS, Kaysen GA, Levin NW, Kliger AS, Beck GJ, Rocco MV, Filler G, Lindsay RM. The effect of increased frequency of hemodialysis on serum cystatin C and ß2-microglobulin concentrations: A secondary analysis of the frequent hemodialysis network (FHN) trial. Hemodial Int. 2019 07; 23(3):297-305. PMID: 30861262.
      Citations:    
    35. Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, Davatzikos C, Desiderio L, Erus G, Fine LJ, Gaussoin SA, Harris D, Hsieh MK, Johnson KC, Kimmel PL, Tamura MK, Launer LJ, Lerner AJ, Lewis CE, Martindale-Adams J, Moy CS, Nasrallah IM, Nichols LO, Oparil S, Ogrocki PK, Rahman M, Rapp SR, Reboussin DM, Rocco MV, Sachs BC, Sink KM, Still CH, Supiano MA, Snyder JK, Wadley VG, Walker J, Weiner DE, Whelton PK, Wilson VM, Woolard N, Wright JT, Wright CB. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA. 2019 02 12; 321(6):553-561. PMID: 30688979.
      Citations:    
    36. Chan CT, Wallace E, Golper TA, Rosner MH, Seshasai RK, Glickman JD, Schreiber M, Gee P, Rocco MV. Exploring Barriers and Potential Solutions in Home Dialysis: An NKF-KDOQI Conference Outcomes Report. Am J Kidney Dis. 2019 03; 73(3):363-371. PMID: 30545707.
      Citations:    
    37. Liou AA, Skiver BM, Yates E, Persad P, Meyer D, Farland AM, Rocco MV. Acute Thrombotic Microangiopathy and Cortical Necrosis Following Administration of Alemtuzumab: A Case Report. Am J Kidney Dis. 2019 05; 73(5):615-619. PMID: 30528935.
      Citations:    
    38. Weir MR, Lakkis JI, Jaar B, Rocco MV, Choi MJ, Kramer HJ, Ku E. Use of Renin-Angiotensin System Blockade in Advanced CKD: An NKF-KDOQI Controversies Report. Am J Kidney Dis. 2018 12; 72(6):873-884. PMID: 30201547.
      Citations:    
    39. O'Lone E, Viecelli AK, Craig JC, Tong A, Sautenet B, Roy D, Herrington WG, Herzog CA, Jafar T, Jardine M, Krane V, Levin A, Malyszko J, Rocco MV, Strippoli G, Tonelli M, Wang AYM, Wanner C, Zannad F, Winkelmayer WC, Webster AC, Wheeler DC. Cardiovascular Outcomes Reported in Hemodialysis Trials. J Am Coll Cardiol. 2018 06 19; 71(24):2802-2810. PMID: 29903353.
      Citations:    
    40. Chan CT, Kaysen GA, Beck GJ, Li M, Lo J, Rocco MV, Kliger AS. Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials. Am J Nephrol. 2018; 47(3):208-217. PMID: 29621747.
      Citations:    
    41. Johnson KC, Whelton PK, Cushman WC, Cutler JA, Evans GW, Snyder JK, Ambrosius WT, Beddhu S, Cheung AK, Fine LJ, Lewis CE, Rahman M, Reboussin DM, Rocco MV, Oparil S, Wright JT. Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension. 2018 05; 71(5):848-857. PMID: 29531173.
      Citations:    
    42. Cheung AK, Chertow GM, Greene T, Kimmel PL, Rahman M, Reboussin D, Rocco M; SPRINT Research Group. Benefits and risks of intensive blood-pressure lowering in advanced chronic kidney disease. J Intern Med. 2018; 284(1):106-7.
    43. Rocco MV, Sink KM, Lovato LC, Wolfgram DF, Wiegmann TB, Wall BM, Umanath K, Rahbari-Oskoui F, Porter AC, Pisoni R, Lewis CE, Lewis JB, Lash JP, Katz LA, Hawfield AT, Haley WE, Freedman BI, Dwyer JP, Drawz PE, Dobre M, Cheung AK, Campbell RC, Bhatt U, Beddhu S, Kimmel PL, Reboussin DM, Chertow GM. Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis. 2018 03; 71(3):352-361. PMID: 29162340.
      Citations:    
    44. Bansal VK, Herzog CA, Sarnak MJ, Choi MJ, Mehta R, Jaar BG, Rocco MV, Kramer H. Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report. Am J Kidney Dis. 2017 Dec; 70(6):859-868. PMID: 28941763.
      Citations:    
    45. Beddhu S, Rocco MV, Toto R, Craven TE, Greene T, Bhatt U, Cheung AK, Cohen D, Freedman BI, Hawfield AT, Killeen AA, Kimmel PL, Lash J, Papademetriou V, Rahman M, Rastogi A, Servilla K, Townsend RR, Wall B, Whelton PK. Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial. Ann Intern Med. 2017 Sep 19; 167(6):375-383. PMID: 28869987.
      Citations:    
    46. Bress AP, King JB, Kreider KE, Beddhu S, Simmons DL, Cheung AK, Zhang Y, Doumas M, Nord J, Sweeney ME, Taylor AA, Herring C, Kostis WJ, Powell J, Rastogi A, Roumie CL, Wiggers A, Williams JS, Yunis R, Zias A, Evans GW, Greene T, Rocco MV, Cushman WC, Reboussin DM, Feinglos MN, Papademetriou V. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care. 2017 Aug 09. PMID: 28793997.
      Citations:    
    47. Cheung AK, Rahman M, Reboussin DM, Craven TE, Greene T, Kimmel PL, Cushman WC, Hawfield AT, Johnson KC, Lewis CE, Oparil S, Rocco MV, Sink KM, Whelton PK, Wright JT, Basile J, Beddhu S, Bhatt U, Chang TI, Chertow GM, Chonchol M, Freedman BI, Haley W, Ix JH, Katz LA, Killeen AA, Papademetriou V, Ricardo AC, Servilla K, Wall B, Wolfgram D, Yee J. Effects of Intensive BP Control in CKD. J Am Soc Nephrol. 2017 Sep; 28(9):2812-2823. PMID: 28642330.
      Citations:    
    48. Upadhya B, Rocco M, Lewis CE, Oparil S, Lovato LC, Cushman WC, Bates JT, Bello NA, Aurigemma G, Fine LJ, Johnson KC, Rodriguez CJ, Raj DS, Rastogi A, Tamariz L, Wiggers A, Kitzman DW. Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial. Circ Heart Fail. 2017 Apr; 10(4). PMID: 28364091.
      Citations:    
    49. Freedman BI, Rocco MV, Bates JT, Chonchol M, Hawfield AT, Lash JP, Papademetriou V, Sedor JR, Servilla K, Kimmel PL, Wall BM, Pajewski NM. APOL1 renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial. Kidney Int Rep. 2017 Jul; 2(4):713-720. PMID: 28758155.
      Citations:    
    50. Lo JC, Beck GJ, Kaysen GA, Chan CT, Kliger AS, Rocco MV, Li M, Chertow GM. Thyroid function in end stage renal disease and effects of frequent hemodialysis. Hemodial Int. 2017 10; 21(4):534-541. PMID: 28301073.
      Citations:    
    51. Rodriguez CJ, Still CH, Garcia KR, Wagenknecht L, White S, Bates JT, Del Cid MV, Lioudis M, Lopez Barrera N, Moreyra A, Punzi H, Ringer RJ, Cushman WC, Contreras G, Servilla K, Rocco M. Baseline blood pressure control in Hispanics: characteristics of Hispanics in the Systolic Blood Pressure Intervention Trial. J Clin Hypertens (Greenwich). 2017 Feb; 19(2):116-125. PMID: 27862904.
      Citations:    
    52. Lo JC, Beck GJ, Kaysen GA, Chan CT, Kliger AS, Rocco MV, Chertow GM. Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis. Hemodial Int. 2017 04; 21(2):190-196. PMID: 27774730.
      Citations:    
    53. Rocco MV, Chapman A, Chertow GM, Cohen D, Chen J, Cutler JA, Diamond MJ, Freedman BI, Hawfield A, Judd E, Killeen AA, Kirchner K, Lewis CE, Pajewski NM, Wall BM, Yee J. Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions. Am J Nephrol. 2016; 44(2):130-40. PMID: 27513312.
      Citations:    
    54. Kramer H, Yee J, Weiner DE, Bansal V, Choi MJ, Brereton L, Berns JS, Samaniego-Picota M, Scheel P, Rocco M. Ultrafiltration Rate Thresholds in Maintenance Hemodialysis: An NKF-KDOQI Controversies Report. Am J Kidney Dis. 2016 10; 68(4):522-532. PMID: 27449697.
      Citations:    
    55. Freedman BI, Gadegbeku CA, Bryan RN, Palmer ND, Hicks PJ, Ma L, Rocco MV, Smith SC, Xu J, Whitlow CT, Wagner BC, Langefeld CD, Hawfield AT, Bates JT, Lerner AJ, Raj DS, Sadaghiani MS, Toto RD, Wright JT, Bowden DW, Williamson JD, Sink KM, Maldjian JA, Pajewski NM, Divers J. APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume. Kidney Int. 2016 08; 90(2):440-449. PMID: 27342958.
      Citations:    
    56. Ma L, Langefeld CD, Comeau ME, Bonomo JA, Rocco MV, Burkart JM, Divers J, Palmer ND, Hicks PJ, Bowden DW, Lea JP, Krisher JO, Clay MJ, Freedman BI. APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease. Kidney Int. 2016 08; 90(2):389-395. PMID: 27157696.
      Citations:    
    57. Hall ME, Rocco MV, Morgan TM, Hamilton CA, Jordan JH, Edwards MS, Hall JE, Hundley WG. Beta-Blocker Use Is Associated with Higher Renal Tissue Oxygenation in Hypertensive Patients Suspected of Renal Artery Stenosis. Cardiorenal Med. 2016 Aug; 6(4):261-8. PMID: 27648007.
      Citations:    
    58. Mehta RL, Burdmann EA, Cerdá J, Feehally J, Finkelstein F, García-García G, Godin M, Jha V, Lameire NH, Levin NW, Lewington A, Lombardi R, Macedo E, Rocco M, Aronoff-Spencer E, Tonelli M, Zhang J, Remuzzi G. Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study. Lancet. 2016 May 14; 387(10032):2017-25. PMID: 27086173.
      Citations:    
    59. Rocco MV, Cheung AK. A SPRINT to the finish, or just the beginning? Implications of the SPRINT results for nephrologists. Kidney Int. 2016 Feb; 89(2):261-3. PMID: 26806825.
      Citations:    
    60. Rocco M, Daugirdas J, Depner T. NKF finalizes update for adequacy guidelines. Nephrol News Issues. 2016 Feb; 30(2):35-6. PMID: 26983183.
      Citations:    
    61. Dixon BS, VanBuren JM, Rodrigue JR, Lockridge RS, Lindsay R, Chan C, Rocco MV, Oleson JJ, Beglinger L, Duff K, Paulsen JS, Stokes JB. Cognitive changes associated with switching to frequent nocturnal hemodialysis or renal transplantation. BMC Nephrol. 2016 Jan 22; 17:12. PMID: 26801094.
      Citations:    
    62. Raimann JG, Chan CT, Daugirdas JT, Depner T, Gotch FA, Greene T, Kaysen GA, Kliger AS, Kotanko P, Larive B, Lindsay R, Rocco MV, Chertow GM, Levin NW. The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network Trials. Blood Purif. 2016; 41(4):277-86. PMID: 26795100.
      Citations:    
    63. Rocco MV. Chronic Hemodialysis Therapy in the West. Kidney Dis (Basel). 2015 Dec; 1(3):178-86. PMID: 27536678.
      Citations:    
    64. Wright JT, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015 Nov 26; 373(22):2103-16. PMID: 26551272.
      Citations:    
    65. Chertow GM, Levin NW, Beck GJ, Daugirdas JT, Eggers PW, Kliger AS, Larive B, Rocco MV, Greene T. Long-Term Effects of Frequent In-Center Hemodialysis. J Am Soc Nephrol. 2016 Jun; 27(6):1830-6. PMID: 26467779.
      Citations:    
    66. Rocco MV, Daugirdas JT, Greene T, Lockridge RS, Chan C, Pierratos A, Lindsay R, Larive B, Chertow GM, Beck GJ, Eggers PW, Kliger AS. Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial. Am J Kidney Dis. 2015 Sep; 66(3):459-68. PMID: 25863828.
      Citations:    
    67. Mehta RL, Cerdá J, Burdmann EA, Tonelli M, García-García G, Jha V, Susantitaphong P, Rocco M, Vanholder R, Sever MS, Cruz D, Jaber B, Lameire NH, Lombardi R, Lewington A, Feehally J, Finkelstein F, Levin N, Pannu N, Thomas B, Aronoff-Spencer E, Remuzzi G. International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet. 2015 Jun 27; 385(9987):2616-43. PMID: 25777661.
      Citations:    
    68. SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. New Engl J Med. 2015; 373(22):2103-2116.
    69. Haller MC, van der Veer SN, Nagler EV, Tomson C, Lewington A, Hemmelgarn BR, Gallagher M, Rocco M, Obrador G, Vanholder R, Craig JC, van Biesen W. A survey on the methodological processes and policies of renal guideline groups as a first step to harmonize renal guidelines. Nephrol Dial Transplant. 2015 Jul; 30(7):1066-74. PMID: 25204317.
      Citations:    
    70. Kramer H, Berns JS, Choi MJ, Martin K, Rocco MV. 25-Hydroxyvitamin D testing and supplementation in CKD: an NKF-KDOQI controversies report. Am J Kidney Dis. 2014 Oct; 64(4):499-509. PMID: 25082101.
      Citations:    
    71. Langefeld CD, Divers J, Pajewski NM, Hawfield AT, Reboussin DM, Bild DE, Kaysen GA, Kimmel PL, Raj DS, Ricardo AC, Wright JT, Sedor JR, Rocco MV, Freedman BI. Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial. Kidney Int. 2015 Jan; 87(1):169-75. PMID: 25029429.
      Citations:    
    72. Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, Fine LJ, Goff DC, Johnson KC, Killeen AA, Lewis CE, Oparil S, Reboussin DM, Rocco MV, Snyder JK, Williamson JD, Wright JT, Whelton PK. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials. 2014 Oct; 11(5):532-46. PMID: 24902920.
      Citations:    
    73. Turner KR, Fisher EC, Hade EM, Houle TT, Rocco MV. The role of perioperative sodium bicarbonate infusion affecting renal function after cardiothoracic surgery. Front Pharmacol. 2014; 5:127. PMID: 24917818.
      Citations:    
    74. Hall ME, Rocco MV, Morgan TM, Hamilton CA, Edwards MS, Jordan JH, Hurie JB, Hundley WG. Chronic diuretic therapy attenuates renal BOLD magnetic resonance response to an acute furosemide stimulus. J Cardiovasc Magn Reson. 2014 Feb 03; 16:17. PMID: 24490671.
      Citations:    
    75. Estrella MM, Jaar BG, Cavanaugh KL, Fox CH, Perazella MA, Soman SS, Howell E, Rocco MV, Choi MJ. Perceptions and use of the national kidney foundation KDOQI guidelines: a survey of U.S. renal healthcare providers. BMC Nephrol. 2013 Oct 24; 14:230. PMID: 24152744.
      Citations:    
    76. Divers J, Palmer ND, Lu L, Langefeld CD, Rocco MV, Hicks PJ, Murea M, Ma L, Bowden DW, Freedman BI. Gene-gene interactions in APOL1-associated nephropathy. Nephrol Dial Transplant. 2014 Mar; 29(3):587-94. PMID: 24157943.
      Citations:    
    77. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Yang PC, Rajagopalan S. Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2106-16. PMID: 23970131.
      Citations:    
    78. Su CT, Yabes J, Pike F, Weiner DE, Beddhu S, Burrowes JD, Rocco MV, Unruh ML. Changes in anthropometry and mortality in maintenance hemodialysis patients in the HEMO Study. Am J Kidney Dis. 2013 Dec; 62(6):1141-50. PMID: 23859719.
      Citations:    
    79. Reeves-Daniel AM, Farney AC, Fletcher AJ, Assimos D, Westcott C, Rogers J, Stratta RJ, Rocco MV, Freedman BI. Ethnicity, medical insurance, and living kidney donation. Clin Transplant. 2013 Jul-Aug; 27(4):E498-503. PMID: 23781870.
      Citations:    
    80. Divers J, Núñez M, High KP, Murea M, Rocco MV, Ma L, Bowden DW, Hicks PJ, Spainhour M, Ornelles DA, Kleiboeker SB, Duncan K, Langefeld CD, Turner J, Freedman BI. JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy. Kidney Int. 2013 Dec; 84(6):1207-13. PMID: 23677244.
      Citations:    
    81. Rocco MV. Does more frequent hemodialysis provide dietary freedom? J Ren Nutr. 2013 May; 23(3):259-62. PMID: 23611557.
      Citations:    
    82. Suri RS, Larive B, Sherer S, Eggers P, Gassman J, James SH, Lindsay RM, Lockridge RS, Ornt DB, Rocco MV, Ting GO, Kliger AS. Risk of vascular access complications with frequent hemodialysis. J Am Soc Nephrol. 2013 Feb; 24(3):498-505. PMID: 23393319.
      Citations:    
    83. Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, Kliger AS. Effect of frequent hemodialysis on residual kidney function. Kidney Int. 2013 May; 83(5):949-58. PMID: 23344474.
      Citations:    
    84. Chan CT, Covic A, Craig JC, Davenport A, Kasiske BL, Kuhlmann MK, Levin NW, Li PK, Locatelli F, Rocco MV, Wheeler DC. Novel techniques and innovation in blood purification: a clinical update from Kidney Disease: Improving Global Outcomes. Kidney Int. 2013 Mar; 83(3):359-71. PMID: 23325091.
      Citations:    
    85. Kramer H, Berns JS, Nally J, Choi MJ, Rocco MV. A decade after the KDOQI CKD guidelines: impact on NKF-KDOQI. Am J Kidney Dis. 2012 Nov; 60(5):694-6. PMID: 23067632.
      Citations:    
    86. Freedman BI, Langefeld CD, Turner J, Núñez M, High KP, Spainhour M, Hicks PJ, Bowden DW, Reeves-Daniel AM, Murea M, Rocco MV, Divers J. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease. Kidney Int. 2012 Oct; 82(7):805-11. PMID: 22695330.
      Citations:    
    87. Hall YN, Larive B, Painter P, Kaysen GA, Lindsay RM, Nissenson AR, Unruh ML, Rocco MV, Chertow GM. Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials. Clin J Am Soc Nephrol. 2012 May; 7(5):782-94. PMID: 22422538.
      Citations:    
    88. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, Daugirdas JT, Kotanko P, Larive B, Levin NW, Mehta RL, Rocco M, Sanz J, Schiller BM, Yang PC, Rajagopalan S. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging. 2012 Mar; 5(2):251-61. PMID: 22360996.
      Citations:    
    89. Sergeyeva O, Gorodetskaya I, Ramos R, Schiller BM, Larive B, Raimann JG, Ting GO, Eggers PW, Chertow GM, Levin NW. Challenges to enrollment and randomization of the Frequent Hemodialysis Network (FHN) Daily Trial. J Nephrol. 2012; 25(3):302-9.
    90. Burrowes JD, Russell GB, Unruh M, Rocco MV. Is nutritional status associated with self-reported sleep quality in the HEMO study cohort? J Ren Nutr. 2012 Sep; 22(5):461-71. PMID: 22056151.
      Citations:    
    91. Levin NW, Raimann JG, Rocco MV. Should the knowledge gained from the Frequent Hemodialysis Network (FHN) trials change dialysis practice? Curr Opin Nephrol Hypertens. 2011 Nov; 20(6):577-82. PMID: 21941177.
      Citations:    
    92. Freedman BI, Langefeld CD, Murea M, Ma L, Otvos JD, Turner J, Antinozzi PA, Divers J, Hicks PJ, Bowden DW, Rocco MV, Parks JS. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans. Nephrol Dial Transplant. 2011 Nov; 26(11):3805-10. PMID: 21931123.
      Citations:    
    93. Rocco MV, Lockridge RS, Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA, Kliger AS, Kliger A, Eggers P, Briggs J, Hostetter T, Narva A, Star R, Augustine B, Mohr P, Beck G, Fu Z, Gassman J, Greene T, Daugirdas J, Hunsicker L, Larive B, Li M, Mackrell J, Wiggins K, Sherer S, Weiss B, Rajagopalan S, Sanz J, Dellagrottaglie S, Kariisa M, Tran T, West J, Unruh M, Keene R, Schlarb J, Chan C, McGrath-Chong M, Frome R, Higgins H, Ke S, Mandaci O, Owens C, Snell C, Eknoyan G, Appel L, Cheung A, Derse A, Kramer C, Geller N, Grimm R, Henderson L, Prichard S, Roecker E, Rocco M, Miller B, Riley J, Schuessler R, Lockridge R, Pipkin M, Peterson C, Hoy C, Fensterer A, Steigerwald D, Stokes J, Somers D, Hilkin A, Lilli K, Wallace W, Franzwa B, Waterman E, Chan C, McGrath-Chong M, Copland M, Levin A, Sioson L, Cabezon E, Kwan S, Roger D, Lindsay R, Suri R, Champagne J, Bullas R, Garg A, Mazzorato A, Spanner E, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Pierratos A, Chan W, Regozo K, Kwok S. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int. 2011 Nov; 80(10):1080-91. PMID: 21775973.
      Citations:    
    94. Rocco MV. Nocturnal home hemodialysis: which of your patients should choose this modality? Contrib Nephrol. 2011; 171:17-24. PMID: 21625085.
      Citations:    
    95. Freedman BI, Andries L, Shihabi ZK, Rocco MV, Byers JR, Cardona CY, Pickard MA, Henderson DL, Sadler MV, Courchene LM, Jordan JR, Balderston SS, Graham AD, Mauck VL, Russell GB, Bleyer AJ. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. Clin J Am Soc Nephrol. 2011 Jul; 6(7):1635-43. PMID: 21597024.
      Citations:    
    96. Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin JJ, Kiger DF, Gautreaux MD, Divers J, Freedman BI. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant. 2011 May; 11(5):1025-30. PMID: 21486385.
      Citations:    
    97. Kaysen GA, Larive B, Painter P, Craig A, Lindsay RM, Rocco MV, Daugirdas JT, Schulman G, Chertow GM. Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial. Am J Kidney Dis. 2011 Jan; 57(1):101-12. PMID: 21184919.
      Citations:    
    98. FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS. In-center hemodialysis six times per week versus three times per week. New Engl J Med. 2010; 363:2287-2300.
    99. Rocco MV, Larive B, Eggers PW, Beck GJ, Chertow GM, Levin NW, Kliger AS. Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials. Am J Kidney Dis. 2011 Jan; 57(1):90-100. PMID: 21122961.
      Citations:    
    100. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010 Dec 09; 363(24):2287-300. PMID: 21091062.
      Citations:    
    101. Gopalakrishnan I, Iskandar SS, Daeihagh P, Divers J, Langefeld CD, Bowden DW, Hicks PJ, Rocco MV, Freedman BI. Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants. Hum Pathol. 2011 Feb; 42(2):291-4. PMID: 21074826.
      Citations:    
    102. Pierce DA, Rocco MV. Trisodium citrate: an alternative to unfractionated heparin for hemodialysis catheter dwells. Pharmacotherapy. 2010 Nov; 30(11):1150-8. PMID: 20973688.
      Citations:    
    103. Chughtai HL, Morgan TM, Rocco M, Stacey B, Brinkley TE, Ding J, Nicklas B, Hamilton C, Hundley WG. Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension. 2010 Nov; 56(5):901-6. PMID: 20837881.
      Citations:    
    104. Leung J, Dwyer J, Hibberd P, Jacques P, Rand W, Rocco MV. Association between adherence to folic acid supplements and serum folate, and plasma homocysteine among hemodialysis patients. J Ren Nutr. 2011 May; 21(3):246-56. PMID: 20650653.
      Citations:    
    105. Pipkin M, Eggers PW, Larive B, Rocco MV, Stokes JB, Suri RS, Lockridge RS. Recruitment and training for home hemodialysis: experience and lessons from the Nocturnal Dialysis Trial. Clin J Am Soc Nephrol. 2010 Sep; 5(9):1614-20. PMID: 20576829.
      Citations:    
    106. Daugirdas JT, Depner TA, Greene T, Levin NW, Chertow GM, Rocco MV. Standard Kt/Vurea: a method of calculation that includes effects of fluid removal and residual kidney clearance. Kidney Int. 2010 Apr; 77(7):637-44. PMID: 20107428.
      Citations:    
    107. Daugirdas JT, Depner TA, Greene T, Levin NW, Chertow GM, Rocco MV, Stokes JB. Effects of reduced intradialytic urea generation rate and residual renal clearance on modeled urea distribution volume and Kt/V in conventional, daily, and nocturnal dialysis. Semin Dial. 2010 Jan-Feb; 23(1):19-24. PMID: 20331814.
      Citations:    
    108. Rocco MV, Berns JS. KDOQI in the era of global guidelines. Am J Kidney Dis. 2009 Nov; 54(5):781-7. PMID: 19800724.
      Citations:    
    109. Eckardt KU, Berns JS, Rocco MV, Kasiske BL. Definition and classification of CKD: the debate should be about patient prognosis--a position statement from KDOQI and KDIGO. Am J Kidney Dis. 2009 Jun; 53(6):915-20. PMID: 19406541.
      Citations:    
    110. McClellan WM, Wasse H, McClellan AC, Kipp A, Waller LA, Rocco MV. Treatment center and geographic variability in pre-ESRD care associate with increased mortality. J Am Soc Nephrol. 2009 May; 20(5):1078-85. PMID: 19321704.
      Citations:    
    111. Hartmann EL, Kitzman D, Rocco M, Leng X, Klepin H, Gordon M, Rejeski J, Berry M, Kritchevsky S. Physical function in older candidates for renal transplantation: an impaired population. Clin J Am Soc Nephrol. 2009 Mar; 4(3):588-94. PMID: 19261824.
      Citations:    
    112. Rocco MV. Disease management programs for CKD patients: the potential and pitfalls. Am J Kidney Dis. 2009 Mar; 53(3 Suppl 3):S56-63. PMID: 19231762.
      Citations:    
    113. Frankenfield DL, Krishnan SM, Ashby VB, Shearon TH, Rocco MV, Saran R. Differences in mortality among Mexican-American, Puerto Rican, and Cuban-American dialysis patients in the United States. Am J Kidney Dis. 2009 Apr; 53(4):647-57. PMID: 19150157.
      Citations:    
    114. Rocco MV. Short daily and nocturnal hemodialysis: new therapies for a new century? Saudi J Kidney Dis Transpl. 2009 Jan; 20(1):1-11. PMID: 19112213.
      Citations:    
    115. Greene T, Daugirdas JT, Depner TA, Gotch F, Kuhlman M; Frequent Hemodialysis Network Study Group; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health. Solute clearances and fluid removal in the frequent hemodialysis network trials. Am J Kidney Dis. 2009; 53(5):835-44.
    116. Daugirdas JT, Depner TA, Greene T, Kuhlmann MK, Levin NW, Chertow GM, Rocco MV. Surface-area-normalized Kt/V: a method of rescaling dialysis dose to body surface area-implications for different-size patients by gender. Semin Dial. 2008 Sep-Oct; 21(5):415-21. PMID: 18945330.
      Citations:    
    117. Daugirdas JT, Levin NW, Kotanko P, Depner TA, Kuhlmann MK, Chertow GM, Rocco MV. Comparison of proposed alternative methods for rescaling dialysis dose: resting energy expenditure, high metabolic rate organ mass, liver size, and body surface area. Semin Dial. 2008 Sep-Oct; 21(5):377-84. PMID: 18945324.
      Citations:    
    118. Vachharajani TJ, Moossavi S, Kaufman T, Rocco M. Central vein hardware: cannot live with it, cannot live without it. Semin Dial. 2009 Sep-Oct; 22(5):588-9. PMID: 18764790.
      Citations:    
    119. Unruh ML, Newman AB, Larive B, Dew MA, Miskulin DC, Greene T, Beddhu S, Rocco MV, Kusek JW, Meyer KB. The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis. J Am Geriatr Soc. 2008 Sep; 56(9):1608-17. PMID: 18721224.
      Citations:    
    120. Wasse H, Speckman RA, Frankenfield DL, Rocco MV, McClellan WM. Predictors of central venous catheter use at the initiation of hemodialysis. Semin Dial. 2008 Jul-Aug; 21(4):346-51. PMID: 18564968.
      Citations:    
    121. Hopson S, Frankenfield D, Rocco M, McClellan W. Variability in reasons for hemodialysis catheter use by race, sex, and geography: findings from the ESRD Clinical Performance Measures Project. Am J Kidney Dis. 2008 Oct; 52(4):753-60. PMID: 18514986.
      Citations:    
    122. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008 Jul 03; 359(1):7-20. PMID: 18492867.
      Citations:    
    123. Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, Himmelfarb J, Vazquez MA, Gassman JJ, Greene T, Radeva MK, Braden GL, Ikizler TA, Rocco MV, Davidson IJ, Kaufman JS, Meyers CM, Kusek JW, Feldman HI. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA. 2008 May 14; 299(18):2164-71. PMID: 18477783.
      Citations:    
    124. Cheung AK, Greene T, Leypoldt JK, Yan G, Allon M, Delmez J, Levey AS, Levin NW, Rocco MV, Schulman G, Eknoyan G. Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2008 Jan; 3(1):69-77. PMID: 18057309.
      Citations:    
    125. Beddhu S, Cheung AK, Larive B, Greene T, Kaysen GA, Levey AS, Rocco M, Sarnak M, Toto R, Eknoyan G. Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr. 2007 Nov; 17(6):372-80. PMID: 17971309.
      Citations:    
    126. Rocco MV. More frequent hemodialysis: back to the future? Adv Chronic Kidney Dis. 2007 Jul; 14(3):e1-9. PMID: 17603969.
      Citations:    
    127. Wasse H, Speckman RA, Frankenfield DL, Rocco MV, McClellan WM. Predictors of delayed transition from central venous catheter use to permanent vascular access among ESRD patients. Am J Kidney Dis. 2007 Feb; 49(2):276-83. PMID: 17261430.
      Citations:    
    128. Suri RS, Garg AX, Chertow GM, Levin NW, Rocco MV, Greene T, Beck GJ, Gassman JJ, Eggers PW, Star RA, Ornt DB, Kliger AS. Frequent Hemodialysis Network (FHN) randomized trials: study design. Kidney Int. 2007 Feb; 71(4):349-59. PMID: 17164834.
      Citations:    
    129. Van Wyck D, Eckardt KU, Uhlig K, Rocco M, Levin A. Appraisal of evidence and control of bias in the kidney disease outcomes quality initiative guideline development process. Clin J Am Soc Nephrol. 2007 Jan; 2(1):8-10. PMID: 17699378.
      Citations:    
    130. Rocco MV, Frankenfield DL, Hopson SD, McClellan WM. Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann Intern Med. 2006 Oct 03; 145(7):512-9. PMID: 17015869.
      Citations:    
    131. Rocco MV. Revisions to KDOQI guidelines released at the NKF 2006 Spring Clinical Meetings. Nephrol News Issues. 2006 Jul; 20(8):40, 42. PMID: 16859232.
      Citations:    
    132. Ng YH, Meyer KB, Kusek JW, Yan G, Rocco MV, Kimmel PL, Benz RL, Beddhu S, Dwyer JT, Toto RD, Eknoyan G, Unruh ML. Hemodialysis timing, survival, and cardiovascular outcomes in the Hemodialysis (HEMO) Study. Am J Kidney Dis. 2006 Apr; 47(4):614-24. PMID: 16564939.
      Citations:    
    133. Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, Agodoa L, Bailey J, Beck GJ, Clark W, Levey AS, Ornt DB, Schulman G, Schwab S, Teehan B, Eknoyan G. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol. 2006 Feb; 17(2):546-55. PMID: 16382021.
      Citations:    
    134. Burrowes JD, Larive B, Chertow GM, Cockram DB, Dwyer JT, Greene T, Kusek JW, Leung J, Rocco MV. Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the Hemodialysis (HEMO) Study. Nephrol Dial Transplant. 2005 Dec; 20(12):2765-74. PMID: 16204298.
      Citations:    
    135. Burrowes JD, Russell GB, Rocco MV. Multiple factors affect renal dietitians' use of the NKF-K/DOQI Adult Nutrition Guidelines. J Ren Nutr. 2005 Oct; 15(4):407-26. PMID: 16198933.
      Citations:    
    136. Dwyer JT, Larive B, Leung J, Rocco MV, Greene T, Burrowes J, Chertow GM, Cockram DB, Chumlea WC, Daugirdas J, Frydrych A, Kusek JW. Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study? Kidney Int. 2005 Oct; 68(4):1766-76. PMID: 16164653.
      Citations:    
    137. Rocco MV. Worldwide experience with incremental peritoneal dialysis. Hong Kong J Nephrol. 2005; 7(2):59-64.
    138. Rocco MV, Cheung AK, Greene T, Eknoyan G. The HEMO Study: applicability and generalizability. Nephrol Dial Transplant. 2005 Feb; 20(2):278-84. PMID: 15615811.
      Citations:    
    139. Speckman RA, Frankenfield DL, Roman SH, Eggers PW, Bedinger MR, Rocco MV, McClellan WM. Diabetes is the strongest risk factor for lower-extremity amputation in new hemodialysis patients. Diabetes Care. 2004 Sep; 27(9):2198-203. PMID: 15333484.
      Citations:    
    140. Rocco MV, Dwyer JT, Larive B, Greene T, Cockram DB, Chumlea WC, Kusek JW, Leung J, Burrowes JD, McLeroy SL, Poole D, Uhlin L. The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: results of the HEMO Study. Kidney Int. 2004 Jun; 65(6):2321-34. PMID: 15149346.
      Citations:    
    141. Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, Lewis J, Rocco M, Toto R, Windus D, Ornt D, Levey AS. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int. 2004 Jun; 65(6):2380-9. PMID: 15149351.
      Citations:    
    142. Frankenfield DL, Roman SH, Rocco MV, Bedinger MR, McClellan WM. Disparity in outcomes for adult Native American hemodialysis patients? Findings from the ESRD Clinical Performance Measures Project, 1996 to 1999. Kidney Int. 2004 Apr; 65(4):1426-34. PMID: 15086485.
      Citations:    
    143. Rocco MV. Poor nutritional status and inflammation: mechanisms and treatment. Semin Dial. 2004; 17(6):425-426.
    144. Cheung AK, Levin NW, Greene T, Agodoa L, Bailey J, Beck G, Clark W, Levey AS, Leypoldt JK, Ornt DB, Rocco MV, Schulman G, Schwab S, Teehan B, Eknoyan G. Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol. 2003 Dec; 14(12):3251-63. PMID: 14638924.
      Citations:    
    145. Frankenfield DL, Ramirez SP, McClellan WM, Frederick PR, Rocco MV. Differences in intermediate outcomes for Asian and non-Asian adult hemodialysis patients in the United States. Kidney Int. 2003 Aug; 64(2):623-31. PMID: 12846759.
      Citations:    
    146. Burrowes JD, Larive B, Cockram DB, Dwyer J, Kusek JW, McLeroy S, Poole D, Rocco MV. Effects of dietary intake, appetite, and eating habits on dialysis and non-dialysis treatment days in hemodialysis patients: cross-sectional results from the HEMO study. J Ren Nutr. 2003 Jul; 13(3):191-8. PMID: 12874743.
      Citations:    
    147. Rocco MV, Frankenfield DL, Prowant B, Frederick P, Flanigan MJ. Response to inadequate dialysis in chronic peritoneal dialysis patients. Results from the 2000 Centers for Medicare and Medicaid (CMS) ESRD Peritoneal Dialysis Clinical Performance Measures (PD-CPM) Project. Am J Kidney Dis. 2003 Apr; 41(4):840-8. PMID: 12666071.
      Citations:    
    148. Frankenfield DL, Rocco MV, Roman SH, McClellan WM. Survival advantage for adult Hispanic hemodialysis patients? Findings from the end-stage renal disease clinical performance measures project. J Am Soc Nephrol. 2003 Jan; 14(1):180-6. PMID: 12506150.
      Citations:    
    149. Reddan DN, Frankenfield DL, Klassen PS, Coladonato JA, Szczech L, Johnson CA, Besarab A, Rocco M, McClellan W, Wish J, Owen WF. Regional variability in anaemia management and haemoglobin in the US. Nephrol Dial Transplant. 2003 01; 18(1):147-52. PMID: 12480973.
      Citations:    
    150. Daugirdas JT, Greene T, Depner TA, Chumlea C, Rocco M, Chertow GM; Hemodialysis (HEMO) Study Group. Anthropometrically estimated total body water volumes are larger than modeled urea volume in chronic hemodialysis patients: effects of age, race, and gender. Kidney Int. 2003; 64(3):1108-1119.
    151. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002 Dec 19; 347(25):2010-9. PMID: 12490682.
      Citations:    
    152. Dwyer JT, Larive B, Leung J, Rocco M, Burrowes JD, Chumlea WC, Frydrych A, Kusek JW, Uhlin L. Nutritional status affects quality of life in Hemodialysis (HEMO) Study patients at baseline. J Ren Nutr. 2002 Oct; 12(4):213-23. PMID: 12382213.
      Citations:    
    153. Reddan D, Klassen P, Frankenfield DL, Szczech L, Schwab S, Coladonato J, Rocco M, Lowrie EG, Owen WF. National profile of practice patterns for hemodialysis vascular access in the United States. J Am Soc Nephrol. 2002 Aug; 13(8):2117-24. PMID: 12138144.
      Citations:    
    154. Rocco MV, Frankenfield DL, Prowant B, Frederick P, Flanigan MJ. Risk factors for early mortality in U.S. peritoneal dialysis patients: impact of residual renal function. Perit Dial Int. 2002 May-Jun; 22(3):371-9. PMID: 12227396.
      Citations:    
    155. Eggers PW, Frankenfield DL, Greer JW, McClellan W, Owen WF, Rocco MV. Comparison of mortality and intermediate outcomes between medicare dialysis patients in HMO and fee for service. Am J Kidney Dis. 2002 Apr; 39(4):796-804. PMID: 11920346.
      Citations:    
    156. Hynes DM, Stroupe KT, Greer JW, Reda DJ, Frankenfield DL, Kaufman JS, Henderson WG, Owen WF, Rocco MV, Wish JB, Kang J, Feussner JR. Potential cost savings of erythropoietin administration in end-stage renal disease. Am J Med. 2002 Feb 15; 112(3):169-75. PMID: 11893342.
      Citations:    
    157. Rocco MV, Paranandi L, Burrowes JD, Cockram DB, Dwyer JT, Kusek JW, Leung J, Makoff R, Maroni B, Poole D. Nutritional status in the HEMO Study cohort at baseline. Hemodialysis. Am J Kidney Dis. 2002 Feb; 39(2):245-56. PMID: 11840364.
      Citations:    
    158. Leypoldt JK, Cheung AK, Delmez JA, Gassman JJ, Levin NW, Lewis JA, Lewis JL, Rocco MV. Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int. 2002 Jan; 61(1):266-75. PMID: 11786109.
      Citations:    
    159. Williams SW, Tell GS, Zheng B, Shumaker S, Rocco MV, Sevick MA. Correlates of sleep behavior among hemodialysis patients. The kidney outcomes prediction and evaluation (KOPE) study. Am J Nephrol. 2002 Jan-Feb; 22(1):18-28. PMID: 11919399.
      Citations:    
    160. Rocco MV, Yan G, Gassman J, Lewis JB, Ornt D, Weiss B, Levey AS. Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration. Am J Kidney Dis. 2002 Jan; 39(1):146-53. PMID: 11774113.
      Citations:    
    161. Flanigan MJ, Rocco MV, Prowant B, Frederick PR, Frankenfield DL. Clinical performance measures: the changing status of peritoneal dialysis. Kidney Int. 2001 Dec; 60(6):2377-84. PMID: 11737613.
      Citations:    
    162. Rocco MV, Bedinger MR, Milam R, Greer JW, McClellan WM, Frankenfield DL. Duration of dialysis and its relationship to dialysis adequacy, anemia management, and serum albumin level. Am J Kidney Dis. 2001 Oct; 38(4):813-23. PMID: 11576885.
      Citations:    
    163. Flanigan MJ, Frankenfield DL, Prowant BF, Bailie GR, Frederick PR, Rocco MV. Nutritional markers during peritoneal dialysis: data from the 1998 Peritoneal Dialysis Core Indicators Study. Perit Dial Int. 2001 Jul-Aug; 21(4):345-54. PMID: 11587396.
      Citations:    
    164. Add additional articles from 1991 to 2002. 2001.
    Rocco's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (392)
    Explore
    _
    Co-Authors (55)
    Explore
    _
    Similar People (52)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _